Author:
Zhang Jing-Zhan,Xie Xiang,Ma Yi-Tong,Zheng Ying-Ying,Yang Yi-Ning,Li Xiao-Mei,Fu Zhen-Yan,Dai Chuan-Fang,Zhang Ming-Ming,Yin Guo-Ting,Liu Fen,Chen Bang-Dang,Gai Min-Tao
Subject
Cell Biology,Neurology (clinical),Geriatrics and Gerontology,Pathology and Forensic Medicine
Reference44 articles.
1. Ito Y, Azrolan N, O'Connell A, Walsh A, Breslow JL (1990). Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science, 249:790-793.
2. Bi N, Yan SK, Liet al. (2005). Polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene in patients with coronary artery disease. Zhonghua Xin Xue Guan Bing Za Zhi, 33:116-121.
3. Isaacs A, Willems SM, Bos D,et al. (2013). Risk scores of common genetic variants for lipid levels influence atherosclerosis and incidentcoronary heart disease. Arterioscler Thromb Vasc Biol, 33:2233-2239.
4. Martinelli N, Trabetti E, Bassi A,et al. (2007). The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study. Atherosclerosis, 191:409-417.
5. Li WW, Dammerman MM, Smith JD, Metzger S, Breslow JL, Leff T (1995). Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J Clin Invest, 96:2601-2605.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献